610 filings
Page 6 of 31
8-K
BLPH
Bellerophon Therapeutics, Inc.
27 Sep 22
Bellerophon Announces FDA Acceptance of Change to Ongoing Phase 3 REBUILD Study of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
8:28am
8-K
BLPH
Bellerophon Therapeutics, Inc.
15 Aug 22
Bellerophon Provides Clinical Program Update and Reports Second Quarter 2022 Financial Results
8:41am
10-Q
2022 Q2
BLPH
Bellerophon Therapeutics, Inc.
Quarterly report
15 Aug 22
8:31am
8-K
BLPH
Bellerophon Therapeutics, Inc.
7 Jun 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
11 May 22
Bellerophon Provides Clinical Program Update and Reports First Quarter 2022 Financial Results
8:34am
10-Q
2022 Q1
BLPH
Bellerophon Therapeutics, Inc.
Quarterly report
11 May 22
8:30am
DEFA14A
BLPH
Bellerophon Therapeutics, Inc.
25 Apr 22
Additional proxy soliciting materials
8:33am
DEF 14A
BLPH
Bellerophon Therapeutics, Inc.
Definitive proxy
25 Apr 22
8:25am
8-K
BLPH
Bellerophon Therapeutics, Inc.
31 Mar 22
Bellerophon Provides Clinical Program Update and Reports Full-Year 2021 Financial Results
4:04pm
10-K
2021 FY
BLPH
Bellerophon Therapeutics, Inc.
Annual report
31 Mar 22
4:02pm
SC 13G/A
New Mountain Investments II, LLC
14 Feb 22
Bellerophon Therapeutics / New Mountain Investments II ownership change
10:45am
4
BLPH
Bellerophon Therapeutics, Inc.
28 Jan 22
Bellerophon Therapeutics / Peter Fernandes ownership change
4:31pm
4
Martin Dekker
28 Jan 22
Bellerophon Therapeutics / Martin Dekker ownership change
4:31pm
4
Parag Suresh Shah
28 Jan 22
Bellerophon Therapeutics / Parag Suresh Shah ownership change
4:30pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
28 Jan 22
Departure of Directors or Certain Officers
4:30pm
4
Nicholas Laccona
28 Jan 22
Bellerophon Therapeutics / Nicholas Laccona ownership change
4:30pm
8-K
BLPH
Bellerophon Therapeutics, Inc.
5 Jan 22
Company Presentation I January 2022Bellerophon Therapeutics
8:39am
4
Cloyd Mary Ann
4 Jan 22
Bellerophon Therapeutics / Mary Ann Cloyd ownership change
4:10pm
4
Theodore T Wang
4 Jan 22
Bellerophon Therapeutics / Theodore T Wang ownership change
4:10pm
8-K/A
BLPH
Bellerophon Therapeutics, Inc.
4 Jan 22
Departure of Directors or Certain Officers
4:10pm